AnalystsInsight

Damon Delmonte (KBW): Analyst Track Record and Price‑Target Accuracy

Damon Delmonte is one of the top‑ranked analysts in Exent’s 7‑year backtest. What Damon covers, how Damon’s ratings lean, how fast price targets were reached and the ratings from before the last 30 days; the full record and the newest calls are members‑only.

Published Updated 2 min readHow we research

Key takeaways

  • Damon Delmonte ranks among the top 50 financials analysts in Exent’s ranking, scored on a 7‑year backtest.
  • The exact rank, price‑target hit rate and live calls are members‑only in Exent Gems.
  • Damon published 2 ratings in the last 30 days, the latest on Oct 16, 2026.
  • Most‑covered stocks: HBNC, MSBI, EBC, BUSE.
  • In the past year Damon’s ratings were 38% Buy, 62% Hold and 0% Sell.

Damon Delmonte’s track record at a glance

Damon Delmonte of KBW ranks among the top 50 financials analysts in Exent’s ranking, with a focus on financials. The top of the ranking is what Exent Gems follows, so Damon’s exact rank, hit rate and live calls are for members.

MetricDamon DelmonteAll analysts
Exent rank—
Price‑target hit rate53.6%
Calls up after 12 months64.6%
Median 12‑month return of calls+13.4%
Median days to hit target91 days
Stocks covered32—

How fast price targets were reached

Time to reach the targetDamon Delmonte
Under 30 days13.4%
30–90 days23.3%
90–180 days28.7%
Over 180 days34.6%

Share of the targets that were reached, by how long they took. Targets are usually set for 12 months.

Stocks Damon Delmonte covers most

HBNC · MSBI · EBC · BUSE · BY · THFF · FISI · EFSC

In the past year Damon’s ratings were 38% Buy, 62% Hold and 0% Sell.

Damon Delmonte’s latest ratings

DateStockActionRatingPrice target
Oct 16, 2026
Oct 15, 2026
Sep 4, 2026EQBKReiterated: HoldHold$55.00
Aug 28, 2026THFFReiterated: HoldHold$84.00
Aug 21, 2026CLBKInitiated Coverage: BuyBuy$14.50
Aug 17, 2026GPNInitiated Coverage: HoldHold$95.00
Aug 13, 2026HBTReiterated: BuyBuy$41.00
Aug 3, 2026TFSLReiterated: HoldHold$18.00
Aug 3, 2026FBIZReiterated: BuyBuy$74.00
Jul 31, 2026CFFNReiterated: HoldHold$9.00
Jul 31, 2026ALRSReiterated: HoldHold$32.00
Jul 31, 2026BUSEReiterated: BuyBuy$34.00
Jul 30, 2026CACReiterated: HoldHold$55.00
Jul 30, 2026GABCRated: HoldHold$51.00
  • Oct 16, 2026
    Stock
    Action
    Rating
    Price target
  • Oct 15, 2026
    Stock
    Action
    Rating
    Price target
  • Sep 4, 2026
    Stock
    EQBK
    Action
    Reiterated: Hold
    Rating
    Hold
    Price target
    $55.00
  • Aug 28, 2026
    Stock
    THFF
    Action
    Reiterated: Hold
    Rating
    Hold
    Price target
    $84.00
  • Aug 21, 2026
    Stock
    CLBK
    Action
    Initiated Coverage: Buy
    Rating
    Buy
    Price target
    $14.50
  • Aug 17, 2026
    Stock
    GPN
    Action
    Initiated Coverage: Hold
    Rating
    Hold
    Price target
    $95.00
  • Aug 13, 2026
    Stock
    HBT
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $41.00
  • Aug 3, 2026
    Stock
    TFSL
    Action
    Reiterated: Hold
    Rating
    Hold
    Price target
    $18.00
  • Aug 3, 2026
    Stock
    FBIZ
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $74.00
  • Jul 31, 2026
    Stock
    CFFN
    Action
    Reiterated: Hold
    Rating
    Hold
    Price target
    $9.00
  • Jul 31, 2026
    Stock
    ALRS
    Action
    Reiterated: Hold
    Rating
    Hold
    Price target
    $32.00
  • Jul 31, 2026
    Stock
    BUSE
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $34.00
  • Jul 30, 2026
    Stock
    CAC
    Action
    Reiterated: Hold
    Rating
    Hold
    Price target
    $55.00
  • Jul 30, 2026
    Stock
    GABC
    Action
    Rated: Hold
    Rating
    Hold
    Price target
    $51.00

Damon published 2 ratings in the last 30 days, the latest on Oct 16, 2026. Ratings from the last 30 days are members‑only in Exent Gems, with the stocks where several top‑ranked analysts agree; older ratings are shown in full.

How Exent scores analysts

Exent replays every rating with a price target over a 7‑year lookback: was the target reached, how long it took, and what the stock returned 1, 3, 6 and 12 months after the call. The star rating and rank combine success rate, average return and the number of ratings, so a few lucky calls do not make a top analyst. Statistics as of Oct 20, 2026; ranking updated Oct 21, 2026. How accurate are analyst price targets overall?

Past performance does not guarantee future results. Historical figures are calculated by Exent from market data and are for education only; they are not investment advice or a recommendation to buy or sell any security.

Follow the analysts with the best records

  1. Exent Gems shows Damon Delmonte’s full record and latest ratings, without the 30‑day delay.
  2. Gems are the stocks where several 4★+ analysts agree: Exent’s shortlist of high‑conviction ideas.
  3. Check any idea against your own portfolio: correlation, concentration and crash exposure before you buy.

Exent is our product. Educational content, not investment advice.

Frequently asked questions

By Exent’s scoring, Damon Delmonte ranks among the top 50 financials analysts in Exent’s ranking, based on a 7-year backtest of price-target hit rate, returns after calls and number of ratings. The exact rank, hit rate and live calls are members-only in Exent Gems (exent.ai/radar). Past accuracy does not guarantee future accuracy.

Damon Delmonte’s price-target hit rate is part of the members-only record in Exent Gems (exent.ai/radar). For comparison, the average analyst’s price targets were reached 53.6% of the time.

Damon Delmonte (KBW) covers 32 stocks, mostly in financials. The most frequently rated are HBNC, MSBI, EBC, BUSE, BY.

Get the picks Wall Street’s best analysts agree on.

Exent tracks 4,000+ analysts, keeps only the elite few with proven records, and surfaces the Gems where they agree.

See this week’s GemsLimited offer$1.95 for full access· full access

Educational content, not investment advice. Examples are illustrative; past performance does not guarantee future results.

DISCLAIMER: Exent AI is an informational research platform and does not provide investment advice, financial advice, or act as an investment adviser, broker-dealer, or fiduciary. All content, analytics, and model outputs are provided for educational and informational purposes only and should not be relied upon as a recommendation to buy, sell, or hold any financial instrument. Investing involves risk, including the possible loss of principal. Exent AI does not execute trades, hold customer funds, or provide brokerage services. Past performance and hypothetical results are not indicative of future results. Third-party data and AI-generated outputs may be incomplete or inaccurate.